The high statistical performance measures provided by the NASNet-Large & SVM strongly suggest the potential of RhoB expression captured on the IHC samples of the rectal-cancer biopsy as a protein biomarker for predicting the 5-year survival rate of rectal-cancer patients without undergoing pRT. Here, RHOB is linked to rectal cancer.